Te Ahumairangi Investment Management Ltd
Position in AZN — Astrazeneca PLC
CIK 1832237
WELLINGTON, Q2
Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,537,907
+$130,427 QoQ
Shares Held
34,479
+6.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#353
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Te Ahumairangi Investment Management Ltd holds $45,755,777 across 8 Drug Manufacturers - General names. AZN ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
31,084 | $7,894,403 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
34,479 | $6,537,907 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,511 | $6,490,663 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
48,936 | $6,182,574 | |
| 5 | PFE |
Pfizer Inc
|
237,946 | $5,729,739 | |
| 6 | ABBV |
AbbVie Inc.
|
21,083 | $5,305,326 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
79,705 | $4,592,602 | |
| 8 | LLY |
ELI LILLY & Co
|
2,520 | $3,022,563 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,537,907 | 34,479 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,407,480 | 32,489 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||